Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Anemia × Peripheral Blood Stem Cell Transplantation × Clear all

Sponsor

Conditions

Multiple Myeloma 46 Hodgkin Disease 43 Leukemia, Myeloid, Acute 41 Lymphoma, Non-Hodgkin 40 Leukemia, Lymphocytic, Chronic, B-Cell 37 Precursor Cell Lymphoblastic Leukemia-Lymphoma 35 Myelodysplastic Syndromes 33 Lymphoma, Mantle-Cell 33 Lymphoma, Large B-Cell, Diffuse 31 Lymphoma, Follicular 28 Leukemia 27 Burkitt Lymphoma 26 Lymphoma 25 Myeloproliferative Disorders 24 Lymphoma, Large-Cell, Immunoblastic 23 Congenital Abnormalities 23 Lymphoma, B-Cell, Marginal Zone 22 Leukemia, Myeloid, Chronic-Phase 21 Leukemia, Myelomonocytic, Chronic 20 Leukemia, Myeloid, Accelerated Phase 20 Waldenstrom Macroglobulinemia 19 Blast Crisis 18 Lymphoma, T-Cell, Cutaneous 16 Lymphoma, Large-Cell, Anaplastic 16 Recurrence 14 Primary Myelofibrosis 14 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 14 Neoplasms, Plasma Cell 14 Sezary Syndrome 12 Myelodysplastic-Myeloproliferative Diseases 12

Interventions

Epoetin Alfa 7 Darbepoetin alfa 5 epoetin beta 4 Cyclophosphamide 4 ACE-011 4 fludarabine 3 Busulfan 3 thymoglobulin 2 luspatercept 2 fludarabine phosphate 2 Lenalidomide 2 Cyclosporine 2 Antilymphocyte Serum 2 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2 vactosertib 1 telapristone acetate 1 ruxolitinib 1 roxadustat 1 obinutuzumab 1 ibrutinib 1 fosphenytoin 1 ferrous sulfate 1 ferric gluconate 1 ferric carboxymaltose 1 Whole-Body Irradiation 1 Thiotepa 1 Therapeutics 1 Surveys and Questionnaires 1 Sugars 1 Sucrose 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡